Protection by a Fourth Dose of BNT162b2 against Omicron in Israel – New England Journal of Medicine Commentary: Mixed Bag for Fourth Dose of Pfizer Vaccine vs Omicron— Real-world data show less infection and severity, but long-term benefit less clear – MedPage Today (free registration required) Related: Perspective: The evidence on 4th doses of covid […]

The post Observational study suggests a fourth dose of the Pfizer vaccine provided additional protection against severe disease in patients 60 years of age or older during the Omicron wave in Israel. appeared first on Links Medicus.